HUMA KHUSRO: Open Payments
NPI 1104929587 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 26 payments from 9 companies in 2025. Trend: 2023 $1,035 · 2024 $93 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| E.R. Squibb & Sons, L.L.C. | 5 | $91 |
| ABBVIE INC. | 4 | $84 |
| Alkermes, Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Lundbeck LLC | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: COBENFY, VRAYLAR, ARISTADA, REXULTI, UZEDY, ABILIFY MAINTENA, FANAPT, APLENZIN.
Industry payments across AL — which companies pay providers there.
